[Angiotensin-converting enzyme inhibitors as first choice drugs in chronic congestive heart failure].
Adamska-Dyniewska
H
H
Zakładu Farmakologii Klinicznej IMW WAM, Lódź.
D000804:Angiotensin II / Q000502:physiology; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D004341:Drug Evaluation; D006333:Heart Failure / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D007703:Peptidyl-Dipeptidase A / Q000502:physiology; D012084:Renin-Angiotensin System / Q000187:drug effects / Q000502:physiology
D000806:Angiotensin-Converting Enzyme Inhibitors; D000804:Angiotensin II; D007703:Peptidyl-Dipeptidase A
Inhibitory konwertazy angiotensyny jako leki pierszej linii w przewlekłej niewydolności krazenia.